CME credits: 0.25

Valid until: 31-10-2019

Claim your CME credit at https://reachmd.com/programs/cme/thrombocytopenia-and-new-pathways-forward/10462/

Thrombocytopenia, or low platelet count, is the most frequent hematologic complication of chronic liver disease, and its impact can be devastating on patient care. Due to the risk of bleeding, patients with thrombocytopenia are blocked from receiving crucial invasive therapeutic and diagnostic procedures, which affects those with severe disease the most. This leads to questions on how to best manage thrombocytopenic patients with chronic liver disease.

This activity will discuss recent advances in therapeutic options for patients with severe thrombocytopenia caused by chronic liver disease.